<table id="ID294" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4 Drug Interactions: Changes in Pharmacokinetic Parameters for Co-administered Drug in the Presence of Nevirapine (All interaction trials were conducted in HIV-1 positive subjects)</caption>
<col width="27%"></col>
<col width="16%"></col>
<col width="14%"></col>
<col width="5%"></col>
<col width="13%"></col>
<col width="13%"></col>
<col width="12%"></col>
<tbody>
<tr>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Co</content>
<content stylecode="bold">-</content>
<content stylecode="bold">administered </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Dose </content>
<content stylecode="bold">of </content>
<content stylecode="bold">Co</content>
<content stylecode="bold">-</content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">administered </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Dose </content>
<content stylecode="bold">regimen </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">of </content>
<content stylecode="bold">Nevirapine </content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">n</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="left" colspan="3" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">% </content>
<content stylecode="bold">change </content>
<content stylecode="bold">of </content>
<content stylecode="bold">co</content>
<content stylecode="bold">- </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">administered </content>
<content stylecode="bold">drug  </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">pharmacokinectic </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">parameters </content>
<content stylecode="bold">( </content>
<content stylecode="bold">90 </content>
<content stylecode="bold">% </content>
<content stylecode="bold">CI</content>
<content stylecode="bold">)</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="left" colspan="4" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Antiretrovirals <br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">AUC<br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Cmax<br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Cmin<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Atazanavir/<br/>Ritonavir<footnote id="ID294_1">§ = C<sub>m</sub>
<sub>i</sub>
<sub>n</sub> below detectable level of the assay</footnote>
<sup>,</sup>
<footnote id="ID294_2">Pediatric subjects ranging in age from 6 months to 12 years</footnote>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">300/100 mg<br/> QD day 4–13,<br/> then 400/100 mg <br/>QD, day 14–23<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">200 mg<br/>BID day <br/>1-23. Subjects <br/>were treated <br/>with Nevirapine<br/> prior to trial entry.<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">23<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="underline">Atazanavir </content>
<content stylecode="underline">
<br/>
</content>
<content stylecode="underline">300</content>
<content stylecode="underline">/</content>
<content stylecode="underline">100 </content>
<content stylecode="underline">mg</content>
<br/>
<br/>↓42 <br/>(↓52 to ↓29)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="underline">Atazanavir </content>
<content stylecode="underline">
<br/>
</content>
<content stylecode="underline">300</content>
<content stylecode="underline">/</content>
<content stylecode="underline">100 </content>
<content stylecode="underline">mg</content>
<br/>
<br/>↓28 <br/>(↓40 to↓14)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="underline">Atazanavir </content>
<content stylecode="underline">
<br/>
</content>
<content stylecode="underline">300</content>
<content stylecode="underline">/</content>
<content stylecode="underline">100 </content>
<content stylecode="underline">mg</content>
<br/>
<br/>↓72<br/> (↓80 to ↓60)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="underline">Atazanavir </content>
<content stylecode="underline">
<br/>
</content>
<content stylecode="underline">400</content>
<content stylecode="underline">/</content>
<content stylecode="underline">100 </content>
<content stylecode="underline">mg</content>
<br/>
<br/>↓19 <br/>(↓35 to ↑2)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="underline">Atazanavir </content>
<content stylecode="underline">
<br/>
</content>
<content stylecode="underline">400</content>
<content stylecode="underline">/</content>
<content stylecode="underline">100 </content>
<content stylecode="underline">mg</content>
<br/>
<br/>↑2 <br/>(↓15 to↑24)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="underline">Atazanavir </content>
<content stylecode="underline">
<br/>
</content>
<content stylecode="underline">400</content>
<content stylecode="underline">/</content>
<content stylecode="underline">100 </content>
<content stylecode="underline">mg</content>
<br/>
<br/>↓59<br/> (↓73 to ↓40)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Darunavir/<br/>Ritonavir<footnote id="ID294_3">Parallel group design; n for nevirapine+lopinavir/ritonavir, n for lopinavir/ritonavir alone.</footnote>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">400/100 mg <br/>BID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>BID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">8<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑24 <br/>(↓3 to ↑57)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑40<br/> (↑14 to ↑73)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑2<br/>(↓21 to ↑32)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Didanosine<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">100-150 mg<br/> BID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>QD x 14 days; <br/>200 mg <br/>BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">18<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">§<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Efavirenz<footnoteref idref="ID294_1"></footnoteref>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">600 mg<br/> QD<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>QD x 14 days;<br/> 400 mg QD x 14 <br/>days<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">17<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓28<br/>(↓34 to↓14)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓12<br/>(↓23 to↑1)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓32 <br/>(↓35 to ↓19)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Fosamprenavir<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">1400 mg <br/>BID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg<br/>BID.<br/>Subjects were <br/>treated with <br/>nevirapine prior to<br/>trial entry.<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">17<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓33 <br/>(↓45 to↓20)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓25<br/>(↓37 to↓10)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓35 <br/>(↓50 to ↓15)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Fosamprenavir<br/>/Ritonavir<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">700/100 mg<br/>BID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>BID. <br/>Subjects were <br/>treated with <br/>nevirapine prior <br/>to trial entry.<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">17<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓11 <br/>(↓23 to ↑3)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓19<br/>(↓32 to ↓4)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Indinavir<footnoteref idref="ID294_1"></footnoteref>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">800 mg <br/>q8H<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>QD x 14 days;<br/>200 mg BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">19<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓31<br/>(↓39 to ↓22)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓15 <br/>(↓24 to ↓4)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓44<br/>(↓53 to ↓33)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Lopinavir<footnoteref idref="ID294_1"></footnoteref>
<sup>,</sup>
<footnote id="ID294_7">↑ = Increase, ↓ = Decrease, ⇔ = No Effect</footnote>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">300/75 mg/m<sup>2</sup> <br/>(lopinavir/ <br/>ritonavir)<footnoteref idref="ID294_7"></footnoteref>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">7 mg/kg <br/>or 4 mg/kg <br/>QD x 2<br/>weeks<br/>; BID x 1<br/> week<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">12,<br/>15<footnote id="ID294_9"> For information regarding clinical recommendations, see <linkhtml href="#ID257">Drug Interactions (7)</linkhtml>.</footnote>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓22 <br/>(↓44 to ↑9)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓14 <br/>(↓36 to ↑16)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓55 <br/>(↓75 to ↓19)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Lopinavir<footnoteref idref="ID294_1"></footnoteref>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">400/100 mg BID (lopinavir/ ritonavir)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg QD x 14 days; 200 mg BID &gt;1 year<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">22,<br/>19<footnoteref idref="ID294_9"></footnoteref>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓27<br/> (↓47 to ↓2)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓19 <br/>(↓38 to ↑5)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓51 <br/>(↓72 to ↓26)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Maraviroc<footnote id="ID294_12">Parallel group design; n=23 for atazanavir/ritonavir + nevirapine, n=22 for atazanavir/ritonavir without nevirapine. Changes in atazanavir PK are relative to atazanavir/ritonavir 300/100 mg alone.</footnote>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">300 mg SD<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg BID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">8<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑1 <br/>(↓35 to ↑55)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑54<br/>(↓6 to↑151)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Nelfinavir<footnoteref idref="ID294_1"></footnoteref>
<br/>
<br/>
<br/>
<br/>Nelfinavir-M8 <br/>metabolite<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">750 mg <br/>TID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">200 mg <br/>QD x 14 days;<br/>200 mg<br/>BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">23<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓32<br/>(↓50 to ↑5)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓62<br/>(↓70 to↓53)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓59 <br/>(↓68 to↓48)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓66 <br/>(↓74 to ↓55)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Ritonavir <br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">600 mg<br/> BID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>QD x 14 days;<br/>200 mg BID x 14 days<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">18<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Stavudine<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">30-40 mg<br/> BID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg<br/>QD x 14 days;<br/>200 mg<br/>BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">22<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">§<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Zalcitabine<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">0.125-0.25 mg <br/>TID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg<br/>QD x 14 days;<br/>200 mg<br/>BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">6<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">§<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Zidovudine<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">100-200 mg<br/>TID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>QD x 14 days;<br/>200 mg <br/>BID x 14 days<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">11<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓28<br/>(↓40 to ↓4)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓30<br/>(↓51 to↑14)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">§<br/>
</td>
</tr>
<tr>
<td align="left" colspan="4" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Other </content>
<content stylecode="bold">Medications</content>
<br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">AUC</content>
<br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">C<sub>m</sub>
<sub>a</sub>
<sub>x</sub>
</content>
<br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">C<sub>m</sub>
<sub>i</sub>
<sub>n</sub>
</content>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Clarithromycin<footnoteref idref="ID294_1"></footnoteref>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/> <br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">500 mg <br/>BID<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">200 mg<br/>QD x 14 days<br/>200 mg <br/>BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">15<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓31<br/>(↓38 to ↓24)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓23<br/>(↓31 to↓14)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓56<br/>(↓70 to ↓36)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">Metabolite 14-OH-<br/>clarithromycin<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑42<br/>(↑16 to ↑73)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑47<br/>(↑21 to↑80)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Ethinyl estradiol<footnoteref idref="ID294_1"></footnoteref>
<br/>
<br/>and<br/>
<br/>
<br/>
<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">0.035 mg <br/>(as Ortho-Novum<sup>®</sup> <br/>1/35)<br/>
<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">200 mg <br/>QD x 14 days;<br/>200 mg<br/>BID x 14 <br/>days<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">10<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓20<br/>(↓33 to ↓3)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">§<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">Norethindrone<footnoteref idref="ID294_1"></footnoteref>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">1 mg <br/>(as Ortho-Novum<sup>®</sup> <br/>1/35)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓19<br/>(↓30 to ↓7)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓16<br/>(↓27 to ↓3)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">§<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Depomedroxy-<br/>progesterone acetate<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">150 mg <br/>every 3 <br/>months<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>QD x 14 days;<br/>200 mg<br/>BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">32<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Fluconazole<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg<br/>QD<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>QD x 14 days;<br/>200 mg <br/>BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">19<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Ketoconazole<footnoteref idref="ID294_1"></footnoteref>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">400 mg <br/>QD<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>QD x 14 days; <br/>200 mg <br/>BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">21<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓72<br/>(↓80 to↓60)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓44<br/>(↓58 to↓27)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">§<br/>
</td>
</tr>
<tr>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Methadone<footnoteref idref="ID294_1"></footnoteref>
<br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Individual <br/>Subject <br/>Dosing<br/>
<br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg<br/> QD x 14 days;<br/>200 mg BID ≥7 days<br/>
<br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">9<br/>
</td>
<td align="justify" colspan="3" stylecode=" Lrule Rrule Botrule Toprule" valign="top">In a controlled pharmacokinetic<br/>trial with 9 subjects receiving<br/>chronic methadone to whom<br/>steady-state nevirapine therapy<br/>was added, the clearance of<br/>methadone was increased by <br/>3-fold, resulting in symptoms <br/>of withdrawal, requiring <br/>dose adjustments in 10 mg<br/>segments, in 7 of the 9 subjects.<br/>Methadone did not have any<br/>effect on nevirapine clearance.<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">Rifabutin<footnoteref idref="ID294_1"></footnoteref>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">150 or 300 mg <br/>QD<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">200 mg <br/>QD x 14 days; <br/>200 mg<br/> BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Toprule" valign="top">19<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑17<br/>(↓2 to ↑40)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑28<br/>(↑9 to↑51)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">Metabolite 25-O-<br/>desacetyl-rifabutin<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑24<br/>(↓16 to ↑84)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑29<br/>(↓2 to↑68)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑22<br/>(↓14 to ↑74)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Rifampin<footnoteref idref="ID294_1"></footnoteref>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">600 mg<br/>QD<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">200 mg <br/>QD x 14 days;<br/>200 mg <br/>BID x 14 days<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">14<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑11<br/>(↓4 to ↑28)<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">⇔<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">§<br/>
</td>
</tr>
</tbody>
</table>